← All supplements
Limited evidenceGut health

HMOs (2'-Fucosyllactose)

The main sugar of human breast milk, now sold as an adult prebiotic. It reliably shifts the adult microbiome toward bifidobacteria, but the few trials in adults show inconsistent clinical benefit.

Evidence last reviewed: August 2026

What the science says

  • Microbiome modulation in adults Moderate evidence

    A randomized controlled trial in older adults showed that a human milk oligosaccharide changed the microbiome along with circulating hormones and metabolites. A separate randomized, double-blind trial found 2'-FL produced only a transient improvement in microbial resilience after antibiotic treatment.

  • IBS symptoms Limited evidence

    A parallel, randomized, double-blind, placebo-controlled study of HMO supplementation in IBS patients did not show clear symptom benefit over placebo, despite promising open-label results beforehand.

  • Infant gut development Moderate evidence

    The strongest evidence for 2'-FL is in infant formula, where it shifts the infant microbiome toward a breastfed pattern. Extrapolating that to adults is not justified by the adult trials.

Dosage & safety

Studied doseAdult trials used roughly 1–5 g per day, with some testing up to 20 g. Most consumer products supply 1–3 g.
SafetyWell tolerated; gas and loose stools at higher doses. Very well characterized safety-wise from infant formula use. Expensive relative to other prebiotics with more clinical evidence.

Scientific references

Where to buy

Referral link — this site may earn a commission on purchases.

Related in Gut health